**Article 1: Fast Track in Internal Medicine Residency (NEJM)**
– Keyword match: 0 pts (no keywords provided)
– Why it matters: 25/35 – Directly relevant to a medical student’s clinical training pathway and decision-making about residency formats
– Field/Subfield: 15 pts (Exact match – Clinical Medicine)
– Recency: 10 pts (published Aug 6, 2026)
– TOTAL: 50 pts
**Article 2: Paediatric Drug Optimization for Sickle Cell Disease (The Lancet)**
– Keyword match: 0 pts
– Why it matters: 35/35 – Highly relevant to improving patient outcomes, evidence-based practice for a common childhood disease
– Field/Subfield: 8 pts (Broader field match – Medicine, but subfield is Child & Adolescent Health)
– Recency: 6 pts (published Oct 1, 2026, ~60 days from Sept 7)
– TOTAL: 49 pts
**Article 3: Missing data (Neurology)**
– No title/content. Lowest priority.
– Score: 0 pts
**Article 4: Salivary protein changes to food smell (Physiology & Behavior)**
– Why it matters: 5 pts (tangentially related to clinical practice)
– Field/Subfield: 8 pts (Medicine but subfield is Neurology, tangential)
– Recency: 10 pts (Sept 7, 2026)
– TOTAL: 23 pts
**Article 5: Vitamin D post-myocardial infarction (European Heart Journal)**
– Why it matters: 35/35 – Directly relevant to acute care decision-making and evidence-based practice in cardiology
– Field/Subfield: 8 pts (Broader field, subfield is Cardiology)
– Recency: 10 pts (Sept 7, 2026)
– TOTAL: 53 pts
**Article 5 wins at 53 pts** – Vitamin D post-MI trial is most clinically relevant for patient outcomes and acute care. Article 2 (sickle cell) at 49 is close. Let me compare: The vitamin D trial directly addresses acute care decision-making and evidence-based treatment post-MI making it highly applicable to real-world patient care.
[SUBJECT] Vitamin D After Myocardial Infarction: New Evidence on Supplementation Harms
Personalized briefing
Discovery of the day · Clinical Medicine
More is not always better: vitamin D supplementation post-myocardial infarction in the Target-D trial
Dear Ibtihal Talal Balubaid, this is your personalized scientific intelligence briefing — curated for your work in Clinical Medicine.
Key finding
Medicine · Cardiology
Discovery of the day
The Target-D randomized controlled trial challenges the routine use of vitamin D supplementation in post-myocardial infarction patients, suggesting that more is not necessarily better in this acute care setting. Researchers found that a higher-dose vitamin D supplementation strategy following myocardial infarction failed to demonstrate improved cardiovascular outcomes, raising questions about the presumed benefits of this widely administered intervention. For a clinician-in-training focused on evidence-based acute care decision-making, these findings underscore the importance of evaluating routine supplementation practices against rigorous trial data rather than assuming benefit from established but unproven agents.
Novelty
78%
Rigor
92%
Significance
90%
Validity
85%
Clarity
82%
Advertisement
GroupRFQ — join group deals on lab & medical equipment. Pool orders, unlock volume pricing. See open deals →
Your briefing is personalized based on your selected fields, keywords, and research interests.
